![Eric Xiao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Xiao
Direktor/Vorstandsmitglied bei
Emboline, Inc.
Profil
Eric Xiao is currently a Director at Emboline, Inc. He previously worked as a Principal at Matrix Capital Management Co. LP from 2018 to 2022 and as a Board Member at Palleon Pharmaceuticals, Inc. from 2020 to 2022.
Mr. Xiao completed his undergraduate degree at Yale University in 2016.
Aktive Positionen von Eric Xiao
| Unternehmen | Position | Beginn |
|---|---|---|
Emboline, Inc.
 Emboline, Inc. Medical SpecialtiesHealth Technology Develops novel embolic protection devices for transcatheter and surgical cardiac procedures | Direktor/Vorstandsmitglied | 25.05.2021 |
Ehemalige bekannte Positionen von Eric Xiao
| Unternehmen | Position | Ende |
|---|---|---|
Matrix Capital Management Co. LP
 Matrix Capital Management Co. LP Investment ManagersFinance Matrix aims to generate an attractive risk-adjusted return by investing in a concentrated portfolio of long and short positions, following the classic hedge fund model. Their strategy is to achieve this goal through maintaining a concentrated portfolio of long and short investments, over the long-term, driven by differentiating research into company fundamentals. The firm performs a fundamental bottom-up analysis to assess a company’s intrinsic value. | Corporate Officer/Principal | 01.02.2022 |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Corporate Officer/Principal | 01.02.2022 |
Ausbildung von Eric Xiao
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Matrix Capital Management Co. LP
Matrix Capital Management Co. LP Investment ManagersFinance Matrix aims to generate an attractive risk-adjusted return by investing in a concentrated portfolio of long and short positions, following the classic hedge fund model. Their strategy is to achieve this goal through maintaining a concentrated portfolio of long and short investments, over the long-term, driven by differentiating research into company fundamentals. The firm performs a fundamental bottom-up analysis to assess a company’s intrinsic value. | Finance |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emboline, Inc.
Emboline, Inc. Medical SpecialtiesHealth Technology Develops novel embolic protection devices for transcatheter and surgical cardiac procedures | Health Technology |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
Wählen Sie MarketScreener 
